Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics

This publication has 29 references indexed in Scilit:

• Relative contribution of cytochromes P‐450 and flavin‐containing monoxygenases to the metabolism of albendazole by human liver microsomes
  British Journal of Clinical Pharmacology, 2000
• Influence of ethanol on gastric absorption and metabolism of albendazole and mebendazole
  Drug and Alcohol Dependence, 1994
• Repeated exposure to Opisthorchis viverrini and treatment with the antihelminthic Praziquantel lacks carcinogenic potential
  Carcinogenesis: Integrative Cancer Research, 1992
• Chiral behaviour of the metabolite albendazole sulphoxide in sheep, goats and cattle
  Research in Veterinary Science, 1991
• The metabolism of benzimidazole anthelmintics
  Parasitology Today, 1990
• Clinical Pharmacokinetics of Anthelmintic Drugs
  Clinical Pharmacokinetics, 1988
• Inducing effect of albendazole on rat liver drug-metabolizing enzymes and metabolite pharmacokinetics
  Toxicology and Applied Pharmacology, 1988
• Sulphoxidation of albendazole by the FAD-containing and cytochrome P-450 dependent mono-oxygenases from pig liver microsomes
  Xenobiotica, 1987
• A correlation of toxicity of albendazole and oxfendazole with their free metabolites and bound residues
  Journal of Veterinary Pharmacology and Therapeutics, 1984
• Praziquantel
  Medicinal Research Reviews, 1983